BackBioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Operating Income

Latest operating income for BIOSU: $-2.2M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1278991.00
400.73% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-2162848.00
283.73% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) (BIOSU) FAQ

As of the most recent data (June 2023), BIOSU shows a operating income of $-2.2M. That compares with $-560K in the prior-year period — down 283.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOSU's operating income is now $-2.2M (was $-560K) — a 283.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) is outperforming or lagging.

Tracking BIOSU's operating income over time shows whether BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $-2.2M That compares with $-560K in the prior-year period — down 283.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-2.2M) with ownership activity and broader fundamentals.